Insecticides (india) Limited · NSE:INSECTICID

Insecticides (india) — Q4 FY2019 Earnings Presentation

20 slides from Insecticides (india)'s earnings presentation, Nov 24, 2019

  1. Slide 1: Q4 and Full Year FY2019 Earnings Presentation

    (BSE: 532851 NSE: INSECTICID) Q4 and Full Year FY2019 Earnings Presentation

  2. Slide 2: FY2019 Highlights

    FY2019 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 11.1% 25.6% 45.8% 11,919 10,733 1,856 1,224 1,478 840 15.6% 10.2% 13.8% 7.8% FY18 FY19 FY18 FY19 FY18 FY19 EBITDA Margin (%) PAT Margin (%) Annual Highlights: • Higher contribution from recently launched pro

  3. Slide 3: Q4 FY2019 Highlights

    Q4 FY2019 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 17.8% 54.7% 271.5% 1,989 289 286 187 1,689 14.3% 14.5% 77 11.0% 4.5% Q4 FY18 Q4 FY19 Q4 FY18 Q4 FY19 Q4 FY18 Q4 FY19 EBITDA Margin (%) PAT Margin (%) Quarterly Highlights: • Higher contribution from recen

  4. Slide 4: Products Freshness Index

    Products Freshness Index Proven track record of successful new product launches exhibits IIL’s strong R&D capabilities and continues to provide competitive edge 535 478 70 Revenue from new product launches (Rs. Cr.) 420 66 89 299 131 148 90 11 13 9 221 33 38 10 45 34 172 30 89 66 41 65 60 69 166 172

  5. Slide 5: Management Commentary

    Management Commentary Commenting on the results, Mr. Rajesh Aggarwal, Managing Director, said: “I am pleased to report that the Company recorded revenue from operations of Rs. 1,192 crores in FY2019, representing a robust growth of 11.1% on Y-o-Y basis. The Company delivered EBITDA of Rs. 186 crores

  6. Slide 6: Growth Strategy

    Growth Strategy Optimum Capital Structure and Phase out Generic Products Backward and Forward Integration Operational Efficiency • Gradual reduction in the sale of • Moving on the strategic path of • Strong cash flow generation Generic products (high volume-low backward and forward integration • Cap

  7. Slide 7: Business Overview

    Business Overview Insecticides India - A Leading Agro Chemicals Manufacturing Company Engaged in the manufacturing and marketing of crop-protection products Rs. 1,192 Cr 60,000+ Four product categories: Insecticides, Herbicides, Fungicides, FY19 Sales Retail Outlets Biologicals and Plant Growth Regu

  8. Slide 8: Capabilities and Geographical Presence

    Capabilities and Geographical Presence R&D Manufacturing • NABL QC Labs • 5 Formulations plant • In-house R&D Centre 01 02 • 2 Technical synthesis plants • JV with OAT Agrio Co. • 1 Biological manufacturing plant* Japan for dedicated R&D Centre Development Marketing & Training 04 03 • Sale & market

  9. Slide 9: Leading Maharatna Brands

    Leading Maharatna Brands PULSOR : Systemic fungicide with preventive and curative action; controls Rice Sheath Blight LETHAL : Organo-phosphorus group of insecticides; controls insects through contact, stomach and vapour action GREEN LABEL : Specialist of weed control in paddy; in line with ‘Make in

  10. Slide 10: Research & Development

    Research & Development State-of-the-art in house R&D centre established in 2005, augmented by product innovation R&D center, formulation R&D centre and biological R&D centre • Approved by DSIR, Ministry of Science and Technology 5 Patents Received • Working on new formulations and new combination pr

  11. Slide 11: Financial Performance

    Financial Performance Q4 Y-o-Y Q3 Q-o-Q Full Year Y-o-Y (Rs. Million) FY2019 FY2018 Growth(%) FY2019 Growth(%) FY2019 FY2018 Growth(%) Operating Revenue (net of excise) 1,989 1,689 17.8% 2,157 (7.8)% 11,919 10,733 11.1% Other Income 10 4 167.5% 9 14.1% 23 32 (28.8)% Total Revenue 1,999 1,693 18.1% 2

  12. Slide 12: Leverage Profile

    Leverage Profile (Rs. Million) FY2017 FY2018 FY2019 Long Term Debt 154 83 13 Short Term Debt 2,212 1,061 3,039 18.5% Return on Equity Total Debt 2,366 1,144 3,052 Cash & Cash Equivalents 68 196 89 Net Debt 2,298 948 2,963 17.4% Total Equity 4,645 5,476 6,613 Return on Capital Employed Net Debt/Equit

  13. Slide 13: Financial Trends - Annual

    Financial Trends - Annual Strong EBITDA and PAT growth with margin improvements every successive years Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 4.8% 19.2% 32.6% CAGR CAGR CAGR 11,919 1,856 1,224 10,733 9,882 9,942 1,478 840 1,114 920 597 15.6% 396 13.8% 10.2% 11.2%

  14. Slide 14: Financial Trends - Quarterly

    Financial Trends - Quarterly Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 17.8% 54.7% 271.5% Y-o-Y Y-o-Y Y-o-Y 4,583 3,189 692 556 430 2,157 340 1,989 1,689 286 320 289 17.4% 15.1% 169 14.3% 187 14.8% 10.7% 9.4% 14.5% 77 11.0% 7.8% 4.5% Q4 FY19 Q1 FY19 Q2 FY19 Q3 FY19 Q

  15. Slide 15: Key Ratios

    Key Ratios Consistently improving return ratios and generating wealth for shareholders Return on Equity Return on Capital Employed Net Debt/Equity Ratio 18.5% 20.2% 15.3% 0.5x 0.5x 17.4% 0.4x 12.9% 14.6% 12.5% 9.8% 0.2x FY16 FY17 FY18 FY19 FY16 FY17 FY18 FY19 FY16 FY17 FY18 FY19 15

  16. Slide 16: Segment Reporting - FY2019

    Segment Reporting - FY2019 Gross Sales by Product Category Gross Sales by Segment 5% 4% 11% Insecticides 31% B2C 29% 55% Herbicides 65% B2B Fungicides Exports PGR Gross Sales vs Internal Consumption Breakdown of Top Seller Range in B2C Sales 45% 47% Maharatna 55% 53% Internal Products Consumption Ot

  17. Slide 17: Segment Reporting - FY2019

    Segment Reporting - FY2019 Gross Sales by Segment (Rs. Mn) Gross Sales by Emphasized Product Category (Rs. Mn) +9% +15% +76% +22% -2% 8,661 4,553 7,951 4,208 4,108 3,743 3,563 4,080 341 602 B2C B2B Exports Maharatna Products Other Products FY18 FY19 FY18 FY19 • Strong growth in sales across technica

  18. Slide 18: FY2020 Outlook

    FY2020 Outlook Opportunities Quarterly Outlook India is currently the world’s fourth largest producer of The quarter is expected to remain subdued due to inadequate agrochemicals. Favourable manufacturing opportunities for rainfall and EL Nino impact which may push sowing of agrochemical companies i

  19. Slide 19: Disclaimer

    Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Insecticides India Limited (“Insecticides India” or the Company) future b

  20. Slide 20: Insecticides (India) Ltd. contact details

    Insecticides (India) Ltd. (CIN: L65991DLl996PLC083909) 401-402, Lusa Tower Azadpur Commercial Complex Delhi - 110033 Telefax: +91 11 - 27679700 - 04 (5 Lines) info@insecticidesindia.com www.insecticidesindia.com

Insecticides (India) — Q4 FY2019 Earnings Presentation on 6ix